Browse by author
Lookup NU author(s): Dr David Sheridan,
Professor Margaret Bassendine
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2015 Macmillan Publishers Limited. All rights reserved. Tissue fibrosis is a core pathologic process that contributes to mortality in ∼45% of the population and is likely to be influenced by the host genetic architecture. Here we demonstrate, using liver disease as a model, that a single-nucleotide polymorphism (rs12979860) in the intronic region of interferon-λ4 (IFNL4) is a strong predictor of fibrosis in an aetiology-independent manner. In a cohort of 4,172 patients, including 3,129 with chronic hepatitis C (CHC), 555 with chronic hepatitis B (CHB) and 488 with non-alcoholic fatty liver disease (NAFLD), those with rs12979860CC have greater hepatic inflammation and fibrosis. In CHC, those with rs12979860CC also have greater stage-constant and stage-specific fibrosis progression rates (P<0.0001 for all). The impact of rs12979860 genotypes on fibrosis is maximal in young females, especially those with HCV genotype 3. These findings establish rs12979860 genotype as a strong aetiology-independent predictor of tissue inflammation and fibrosis.
Author(s): Eslam M, Hashem AM, Leung R, Romero-Gomez M, Berg T, Dore GJ, Chan HLK, Irving WL, Sheridan D, Abate ML, Adams LA, Mangia A, Weltman M, Bugianesi E, Spengler U, Shaker O, Fischer J, Mollison L, Cheng W, Powell E, Nattermann J, Riordan S, McLeod D, Armstrong NJ, Douglas MW, Liddle C, Booth DR, George J, Ahlenstiel G, Ampuero J, Bassendine M, Wong VWS, Rosso C, White R, Mezzabotta L, Suppiah V, Michalk M, Malik B, Matthews G, Applegate T, Grebely J, Fragomeli V, Jonsson JR, Santaro R
Publication type: Article
Publication status: Published
Journal: Nature Communications
Online publication date: 05/03/2015
Acceptance date: 28/01/2015
ISSN (print): 2041-1723
Publisher: Nature Publishing Group
Altmetrics provided by Altmetric